fbpx
1-888-310-4540 (main) / 1-888-707-6150 (support) info@spkaa.com
Select Page

Cybersecurity

5 Steps to Standardize Security in DevOps

5 Steps to Standardize Security in DevOps

Although security has always been a priority for developers, new technologies have made it one of the most prominent aspects of DevOps.  This has resulted in the coined term “DevSecOps”, with many companies offering new “DevSecOps platforms.”  With hackers developing...

SPK Secures SOC 2 Type 1 Certification for Enhanced Service Offering

SPK Secures SOC 2 Type 1 Certification for Enhanced Service Offering

SCOTTS VALLEY, CA - Engineering and IT leader SPK and Associates is pleased to announce its achievement of SOC 2 Type 1 certification.  The SOC 2 Type 1 certification attests that SPK’s information security meets or exceeds the rigorous standards set forth by AICPA....

The Top 5 Security Risks of Using Unsupported Software

The Top 5 Security Risks of Using Unsupported Software

As the push towards SaaS solutions intensifies, you may be left wondering why so many businesses are in support of this transition.  Migrating to the cloud is often beneficial, but remaining on-premise can also have negative impacts.  For example, Atlassian is no...

How to Shield Your Digital Assets from AI-Enhanced Ransomware Threats

How to Shield Your Digital Assets from AI-Enhanced Ransomware Threats

The rise of AI has led to many incredible advancements in the digital world. With this new helpful technology, also comes individuals who want to use it for harm. Ransomware attacks were common before AI came into the picture, and with the help of A, they are harder...

CAPA:  A Review of 21 C.F.R. §820.100 and FDA Warning Letter Trends

CAPA: A Review of 21 C.F.R. §820.100 and FDA Warning Letter Trends

SPK and Associates routinely review warning letters to help our clients stay in step with FDA trends.   One of the problem areas most often cited in company audits continue to be the CAPA system/program.   This month we will take a look at some of the latest FDA...